Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 21,120 shares at $41.07 ($875K) on 2025-10-30, disclosed to the SEC on 2025-10-30.
Scheduled sale ($875k) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.56 | 3,520 | $146K | 16.7% |
| 2 | $41.56 | 3,520 | $146K | 16.7% |
| 3 | $41.66 | 3,520 | $147K | 16.8% |
| 4 | $41.66 | 3,520 | $147K | 16.8% |
| 5 | $41.07 | 3,520 | $145K | 16.5% |
| 6 | $41.07 | 3,520 |
| $145K |
| 16.5% |
| Total | $41.43 avg | 21,120 | $875K | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |